On the other hand, the O-GlcNAc modification has been shown to activate NFκb under increase glucose concentrations in vascular smooth muscle cells in diabetes and obesity, suggesting a pro-inflammatory phenotype (45). Here, NFKB1 is linked to diabetes mellitus.